Chugai Pharmaceutical Co., Ltd. (TYO:4519)
9,200.00
+178.00 (1.97%)
At close: Feb 12, 2026
Chugai Pharmaceutical Employees
Chugai Pharmaceutical had 7,872 employees as of December 31, 2025. The number of employees increased by 2,846 or 56.63% compared to the same quarter last year.
Employees
7,872
Change (1Y)
2,846
Growth (1Y)
56.63%
Revenue / Employee
250.29M JPY
Profits / Employee
86.35M JPY
Market Cap
15.14T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,872 | 2,846 | 56.63% |
| Dec 31, 2024 | 5,026 | -2,578 | -33.90% |
| Dec 31, 2023 | 7,604 | -167 | -2.15% |
| Dec 31, 2022 | 7,771 | 107 | 1.40% |
| Dec 31, 2021 | 7,664 | 109 | 1.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Otsuka Holdings | 35,338 |
| Daiichi Sankyo Company | 19,765 |
| Astellas Pharma | 13,643 |
| Kyowa Kirin | 5,669 |
| Ono Pharmaceutical | 4,287 |
| Santen Pharmaceutical | 3,849 |
| JCR Pharmaceuticals | 987 |
| Perseus Proteomics | 32 |
Chugai Pharmaceutical News
- 6 days ago - Japanese drugmakers slump after Trump unveils discount drug website - Reuters
- 14 days ago - Chugai Pharmaceutical Co., Ltd. (CHGCY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Chugai Pharmaceutical reports FY results - Seeking Alpha
- 14 days ago - Chugai Pharmaceutical Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 14 days ago - Chugai Pharma FY25 Results Climb, Sees Growth In FY26 Core Profit, Revenues - Nasdaq
- 4 weeks ago - Chugai Pharmaceutical Co., Ltd. (CHGCY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 2 months ago - Chugai Pharmaceutical Teams With Biomy For Development Of AI-based Cancer Pathology Program - Nasdaq
- 3 months ago - Chugai Pharmaceutical 9-month Net Income Rises - Nasdaq